DSCV.L vs UFPT
DSCV.L: A designer and manufacturer of customized electronic components and systems for industrial and high-reliability applications. UFPT: A specialized contract manufacturer producing custom single-use and single-patient medical devices for major OEMs across minimally invasive surgery, wound care, orthopedics, and biopharma applications.
Side-by-side fundamentals
| Metric | DSCV.L | UFPT | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £7.74 | $322.06 | |
| Market cap as of 2026-08-06 | n/a | $2.5B | |
| P/E as of 2026-08-06 | n/a | 35.13 | |
| PEG as of 2026-08-06 | n/a | 4.77 | |
| Net margin as of 2026-08-06 | n/a | +11.4% | |
| Gross margin as of 2026-08-06 | n/a | +28.5% | |
| Operating margin as of 2026-08-06 | n/a | +15.3% | |
| ROE as of 2026-08-06 | n/a | +16.7% | |
| ROA as of 2026-08-06 | n/a | +10.8% | |
| Debt / equity as of 2026-08-06 | n/a | 0.25 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | +7.3% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +22.7% | |
| Beta as of 2026-08-06 | n/a | 1.07 | |
| 1-year return as of 2026-08-03 close | +14.8% | +33.8% | UFPT higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.